Related Experiment Video
Updated: Jul 5, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
The role of heart rate reduction in angina management and beyond
1Cardiology Department, Prince Philip Hospital, Llanelli SA14 8DR.
Insights
Elevated heart rate is a significant risk for cardiovascular disease. This review explores medications that effectively lower heart rate to improve patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart rate is an independent predictor of cardiovascular disease (CVD) risk.
- Elevated heart rate serves as a prognostic marker in patients with established CVD.
Purpose of the Study:
- To underscore the clinical importance of heart rate in cardiovascular health.
- To review available pharmacological strategies for heart rate reduction.
Main Methods:
- Literature review of studies on heart rate and cardiovascular outcomes.
- Analysis of pharmacological agents targeting heart rate modulation.
Main Results:
- Heart rate is a modifiable risk factor for cardiovascular events.
- Several drug classes demonstrate efficacy in lowering heart rate.
Conclusions:
- Targeting heart rate reduction is a viable therapeutic strategy in CVD management.
- Pharmacological interventions offer effective means to mitigate cardiovascular risk associated with elevated heart rate.
Abstract:
This article highlights the significance of heart rate as an independent risk factor and prognostic marker for cardiovascular disease and examines the pharmacological measures available that lead to effective heart rate reduction.
Related Concept Videos
Angina V: Nursing Management
Angina IV: Management
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Heart Failure V: Medical Management
Coronary Artery Disease V: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
